SCHEMBL7519293

SCHEMBL7519293

C#CCN1CC(C)OC(C)C1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.44
EBP Q15125 2/20 0.44
KDM4E B2RXH2 5/20 0.41
HTT P42858 1/20 0.41
CYP2A13 Q16696 1/20 0.39
PDK1 Q15118 1/20 0.38
ALDH1A1 P00352 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
POLB P06746 2/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31275518 1.00 SIGMAR1 (0.44) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL17148729 0.78
SCHEMBL23638497 0.77 SIGMAR1 (0.44) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL5805370 0.77 SIGMAR1 (0.44) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL23633009 0.77 SIGMAR1 (0.44) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL24951989 0.77 SIGMAR1 (0.44) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL26817726 0.75 PDK1 (0.41) PDK1
SCHEMBL6133223 0.74 SIGMAR1 (0.41) SIGMAR1EBPKDM4EHTTCYP2A13
SCHEMBL17136154 0.73 TSHR (0.35) SIGMAR1KDM4EHTTALDH1A1TSHR
SCHEMBL22561533 0.73 TSHR (0.35) SIGMAR1KDM4EHTTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794009-B1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2017-08-30 EP claimed
US-20250257076-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2025-08-14 US disclosed
US-20020111273-A1 Dihydrobenzene pesticides SZCZEPANSKI HENRY (CH) 2002-08-15 US disclosed
EP-0907634-B1 PESTICIDES BAYER AG (DE) 2002-01-30 EP disclosed
EP-0912499-B1 PESTICIDES BAYER AG (DE) 2001-12-12 EP disclosed
US-6316389-B1 PEST CONTROL, IN PARTICULAR AS FUNGICIDES, ACARICIDES AND INSECTICIDES IN CROP PROTECTION. BAYER AKTIENGESELLSCHAFT (DE) 2001-11-13 US disclosed
US-6288071-B1 FUNGICIDES, INSECTICIDES, MITICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed
EP-0912499-A1 PESTICIDES Novartis AG (CH) 1999-05-06 EP disclosed
EP-0907634-A1 PESTICIDES Novartis AG (CH) 1999-04-14 EP disclosed
WO-1997049672-A1 PESTICIDES NOVARTIS AG (CH) 1997-12-31 WO disclosed
WO-1997047592-A1 PESTICIDES NOVARTIS AG (CH) 1997-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257076-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS CGAS, SSB, FPGS SIGMAR1 4506/4885EBP 3496/4885KDM4E 3122/4885
US-20020111273-A1 Dihydrobenzene pesticides CYP8B1, CBR1, DHCR24 SIGMAR1 396/4885EBP 174/4885KDM4E 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.